Adithya Balasubramanian ten23 health

With over 15 years of experience in the biotech industry, including key positions at Genentech, Regeneron, and Lonza, Adi is an accomplished Business Development Director at ten23 health. Adi's expertise encompasses external collaborations, alliance management, and pharmaceutical development, with a particular focus on formulation development and in-use stability and compatibility. At ten23 health, Adi’s primary responsibilities include identifying new business opportunities, building the ten23 brand, and providing strategic and tactical guidance to the Development teams. Adi began his career as a Research Associate at Regeneron and Genentech, contributing to significant projects such as Eylea (Aflibercept), Praluent (Alirocumab), and Polivy (Polatuzumab vedotin). He also played a pivotal role in establishing the technical operations team at ten23 health and Lonza Drug Product Services. Above all, Adi's true passion lies in creating innovative solutions that enhance patient outcomes and experiences, driving forward the mission of improving healthcare through biotechnology.